Dr. Peter Rowe’s Responses to Follow-Up Webinar Questions

July 24, 2015

On July 16, the Solve ME/CFS Initiative hosted a webinar with Dr. Peter Rowe, director of the Chronic Fatigue Clinic at Johns Hopkins Children’s Center, called, “Inducing Post-Exertional Malaise in ME/CFS: A Look at the Research Evidence. Read More…

Dr. Lily Chu Q&A Follow-Up to June 18 Webinar

July 2, 2015

The Solve ME/CFS Initiative hosted a webinar with Dr. Lily Chu June 18 called, “Post-Exertional Malaise: History, Characteristics, Evidence.” Dr. Chu has followed up with her responses to questions that were unable to be answered during the webinar due to time limitations. Read More…

Pathways to Prevention

June 24, 2015

Last week’s long-awaited briefing on the National Institute of Health’s Pathways to Prevention (P2P) report on ME/CFS failed miserably at continuing the momentum created earlier this year by the Feb. 10 Institute of Medicine publication on the disease. Read More…

Solve ME/CFS Initiative Reappointed to CFSAC Position

June 11, 2015

The Solve ME/CFS Initiative has been reappointed as one of the liaison organizations for the Chronic Fatigue Syndrome Advisory Committee (CFSAC) for the term May 2015 through May 2017. Read More…

Preliminary Results from Synergy Trial Released

May 14, 2015

The long-awaited preliminary results from the K-PAX Synergy Trial are out. While both the patient group and control groups showed improvements, the difference between the two was not statistically significant. The Synergy Trial was designed to produce an FDA-approvable treatment for ME/CFS. Read More…

SMCI Comment on the Institute of Medicine Report—Part 5

April 30, 2015

This is the fifth and final blog post that provides insights into the Institute of Medicine’s report on ME/CFS. In this post, SMCI Scientific Director Dr. Suzanne Vernon focuses on cognitive impairment and orthostatic intolerance, one or both of which are required for an ME/CFS/SEID diagnosis, according to the IOM’s recommended criteria.